• Politics
  • Diversity, equity and inclusion
  • Financial Decision Making
  • Telehealth
  • Patient Experience
  • Leadership
  • Point of Care Tools
  • Product Solutions
  • Management
  • Technology
  • Healthcare Transformation
  • Data + Technology
  • Safer Hospitals
  • Business
  • Providers in Practice
  • Mergers and Acquisitions
  • AI & Data Analytics
  • Cybersecurity
  • Interoperability & EHRs
  • Medical Devices
  • Pop Health Tech
  • Precision Medicine
  • Virtual Care
  • Health equity

Nview Health Receives $4.65M for Digital Behavioral Health Solution


The cloud-based tech could help providers more accurately screen for mental health disorders.


Nview Health today announced it received a $4.65 million investment for its online behavioral health solutions that help providers and researchers more accurately screen for and monitor mental health disorders.

A developer of behavioral health solutions, Nview Health’s core diagnostic platform is the Mini International Neuropsychiatric Interview (M.I.N.I.), which is an online interview designed to identify more than 20 behavioral health disorders.

The cloud-based solution is HIPAA-compliant and is available on any web-enabled device, Nview Health claims. With the digital health solution, screenings and interviews can be administered in a specialist’s office or at home.

“Non-diagnosis and misdiagnosis of behavioral health issues are pervasive problems across our nation’s healthcare providers, resulting in unnecessary complications for patients and unnecessary costs for our healthcare system,” said Jim Szyperski, CEO of Nview Health.

Nview Health’s technology sends automated notifications to providers for patients having suicidal thoughts, impulses, plans, intent and behaviors.

Data collected can be loaded into the provider’s electronic health record and could help providers meet quality care guidelines for mental health, to manage costs and be reimbursed adequately for their time and expense, the company said.

The seed funding came from venture investment firm BIP Capital.

“Nview Health’s M.I.N.I. is considered the gold standard for assisting in the diagnosis of behavioral health disorders,” said Dan Drechsel, MBA, senior vice president at BIP Capital. “We’re pleased to invest in the company because of the positive impact it’s having on the way mental disorders are identified and treated.”

M.I.N.I. has been accepted by the U.S. Food and Drug Administration and endorse by the National Institutes of Health and World Health Organization. The interview has been used in clinical and research settings for more than 25 years and has been referenced or validated in more than 10,000 clinical trials, Nview Health said.

The company will use the funding to fulfill its mission of bringing behavioral health innovation to the broader medical community.

Digital behavioral health solutions have been a focus for many developers and investors over the past year.

In April, Sonde Health announced a $16 million funding round to expand its voice-based platform that monitor and diagnosis physical and mental medical conditions.

And other companies like Meru Health received funding for phone-based digital therapeutics programs for mental illnesses, which aim to improve access to behavioral healthcare.

Get the best insights in digital health directly to your inbox.


Digital Health App Promising in Tandem with Counseling

Young People Using More Mental Health Services, Analysis of 28B Records Shows

Reducing Depression Symptoms with Digital Health Tools

Related Videos
Related Content
© 2024 MJH Life Sciences

All rights reserved.